Switch Biotech AG
6Patents
2Active
6Granted
30Portfolio score
Filing activity: May 10, 1999 → Feb 22, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6303308A | Cloning vectors and their preparation and use for mRNA expression pattern analysis | Chemistry; Metallurgy | 5 | Expired |
| US6586185B2 | Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances | Human Necessities | 4 | Expired |
| US7255988B2 | Use of α 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances | Chemistry; Metallurgy | 3 | Expired |
| US6838272B2 | Filtration process for separating viruses | Chemistry; Metallurgy | 2 | Expired |
| US8268785B2 | Use of a Pde 5 inhibitor for treating and preventing hypopigmentary disorders | Human Necessities | 0 | Active |
| US8329656B2 | Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.